Value through Innovation

main navigation

jump to contentto meta navigation
Cancer News and Information

page content

jump to main navigationto meta navigation

Cancer News and Information

This section includes information and resources about Cancer for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Cancer Press Releases

27.09.2011 BIBF 1120* in patients with metastatic colorectal cancer as effective as bevacizumab with less serious adverse events - FOR NON-US MEDIA ONLY
29.08.2011 Boehringer Ingelheim Broadens its Breast Cancer Trial Programme for Afatinib* - FOR NON-US MEDIA ONLY
09.12.2010 New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib* in lung cancer patients likely to have EGFR mutations - For non-US Media only
11.10.2010 Afatinib (BIBW 2992*) triples progression free survival in phase III study in lung cancer patients - For non-US media only
17.09.2010 Boehringer Ingelheim Initiates Phase III Clinical Trial with Novel Oral Agent in Advanced Breast Cancer
21.05.2010 Boehringer Ingelheim’s lead investigational oncology compound BIBW 2992 demonstrates potential as a next generation treatment for non-small cell lung cancer and head-and-neck cancer

Upcoming Events 2012

  • SABCS
    6-10 December - SABCS - San Antonio Breast Cancer Symposium,
    San Antonio, Texas

Cancer Video Gallery

  • Prof. James Spicer
    Oncology: Information on signal transduction inhibition

Cancer Image Gallery 

back to top

Media Contact

Media Contact
Our media contacts

Other News & Press Releases

boehringer-ingelheim.com

Boehringer Ingelheim offers an optimized solution for mobile devices
Solution for mobile devices

Oncology and white room

No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player

News & Press Releases

News